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Absence of SV40 and Other Polyomavirus (JCV, BKV) DNA in
Primary Cutaneous B Cell Lymphomas
To the Editor:
The pathogenesis of B cell lymphomas is still far from clear.
An association between infectious agents and lymphoma
development has been demonstrated for MALT lymphomas
of the stomach caused by the Helicobacter pylori infection,
and persistent initial primary cutaneous B cell lymphomas
(PCBCL) triggered by the Borrelia burgdorfferi infection
(Cerroni et al, 1997). Besides bacteria, virus particles have
been found in lymphoma cells, such as EBV in Burkitt’s
lymphoma (Niedobitek et al, 2001) and a viral cause has
been postulated to increase the risk for non-Hodgkin
lymphomas in general (Butel, 2000).
The human polyomaviruses BKV, JCV, and simian virus
40 (SV40) induce tumors in laboratory animals (Imperiale,
2000). Moreover, SV40 has been reported to be associated
with various human tumors such as mesotheliomas, bone,
and brain tumors or sarcomas, but this matter is contro-
versial (zur Hausen, 2003; Tognon et al, 2004). SV40 has
also been found in nodal diffuse large B cell, follicular,
and Burkitt’s lymphomas (Vilchez et al, 2002). In contrast,
other investigations have shown a rare occurrence of SV40
in non-Hodgkin lymphoma (Rizzo et al, 1999). In this journal,
it was recently reported, that SV40 DNA is not present in
various cutaneous B and T cell lymphomas (Yazdi et al,
2003).
In our study, paired skin biopsies and corresponding pe-
ripheral blood mononuclear cell (PBMC) samples from 20
patients with PCBCL, 16 males, four females, mean age
49.5 y, ranging from 29 to 84 y, were assessed for the
presence of polyomavirus DNA, in particular SV40, and also
BKV and JCV. The blood samples were taken within 1 mo
before or after the time of skin biopsy. Nineteen patients
were Caucasians, born and living in Germany whereas one
African patient has been living in Germany for 10 y. The
cases were classified as 13 follicle center cell lymphomas
(FCCL), six marginal zone lymphomas (MZL), and one large
B cell lymphoma on leg (DLBCL) according to the EORTC
(Willemze et al, 1997). One patient was also HIV infected.
The medical ethic committee of the Humboldt-University
Berlin, Medical Faculty (Charite´) approved all described
studies and the participants gave their written informed
consent. The study was conducted according to the
Declaration of Helsinki Principles. The frequencies of ma-
lignant B cells quoted to all cells in the biopsy samples
which have been estimated according to histology and
immunophenotyping were at 10%–70% in FCCL, 5%–10%
in MZL, and 90% in the DLBCL. DNA was isolated from
snap-frozen punch biopsies that had been stored at 801C
with liquid nitrogen and from PBMC as described before
(Lukowsky, 2003). Following purification, the concentration
of DNA was calculated by absorbance readings at 260 and
280 nm. A DNA input of 100–200 ng in each PCR (final
volume 25 mL) was always applied. The quality of each DNA
sample was ensured by successful PCR using a primer pair
specific for a 268 bp fragment of the conserved region of
human b-globin gene (Coutlee et al, 2000). For virus DNA
detection the following PCR primer pairs were used:
SV3.for/SV.rev, Pyv.for/Pyv.rev, and SV2.for/SV.rev to am-
plify 106, 172, and 576 bp fragments of the large T-antigen
gene (Tag) of SV40, and, in case of Pyv.for/Pyv.rev, also of
BKV and JCV (Rizzo et al, 1999). Moreover, the primer set
PEP-1/PEP-2 (Arthur et al, 1989) designed to amplify Tag
sequences of BKV (176 bp) and JCV (173 bp), but not of
SV40, was applied. The PCR conditions were chosen as
described elsewhere (Arthur et al, 1989; Rizzo et al, 1999).
Plasmid DNA as positive controls (SV40: pSV40, JCV: pHC
264, BKV: pBR, Kreatech Diagnostics, Amsterdam, the
Netherlands), as well as negative controls without DNA in-
put, were included in each analysis. PCR products were
separated by electrophoresis using an ethidium bromide-
stained 3.3% agarose gel (2.5% Nusieve Agarose, 0.8%
Agarose) and visualized by UV light. By these methods 1.8
pg of pHC 264 as well as pBR and 36 pg of pSV40 plasmids
corresponding to approximately 660, 330, and 6300 DNA
copies were yet clearly detectable. For detection of SV40
DNA, a more sensitive PCR-ELISA was additionally applied.
For this technique we used the primers SV2.for/ SV.rev in a
DIG-labeling reaction, followed by hybridization with a bio-
tin-labeled capture probe (SV40 probe, David et al, 2001)
and ELISA on streptavidin-coated microplates (Roche Ap-
plied Science, Mannheim, Germany) according to the man-
ufacturer’s guide. We have found using other virus DNA
(HBV, CMV, HSV1/ 2, VZV, and HCV) that this method is
capable of detecting a minimum input of at least 10–30
copies of target DNA.
Using the above methods, SV40, BKV, or JCV virus gen-
ome DNA was not found, either in the skin biopsies or in the
blood samples of any of the 20 patients investigated.
Considering this finding, it should be stressed that up to
80% of the adult population worldwide is seropositive for
BK and JC viruses. For SV40 this frequency varies between
2% and 20% in different studies (Kwak et al, 2002). The
major source of known human exposure to SV40 was the
immunization with contaminated poliovaccines; however,
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there is no information about contamination of poliovaccine
with SV40 in Germany or Europe. Nevertheless, SV40 DNA
has been found in malignant mesotheliomas in both German
and North American patients in considerable frequencies
(Shivapurkar et al, 1999). Except for one, all of our patients
were given poliovaccine during their childhood, but no SV40
DNA was found in their peripheral blood lymphocytes.
Polyomaviruses typically provoke sub-clinical and per-
sistent infections in their natural hosts, permanently occur-
ring in different organs, including kidneys, brain, and spleen.
In addition, polyomaviruses can be lymphotropic because
JCV, BKV, and SV40 DNA sequences have been also de-
tected in B lymphocytes from HIV-infected and uninfected
patients (Kwak et al, 2002). Our study indicates that SV40
DNA is not present in PCBCL in patients not infected by HIV
and confirms the results of Yazdi et al (2003). It remains to
be clarified whether the lack of epidemic SV40 infection in
Europe is the reason for the absence of SV40 genome in
PBCL, or whether the etiology of PCBCL is completely in-
dependent of epidemic infection by these polyomaviruses.
The circulation of SV40 among humans and the prevalence
of infection has still to be established.
Here, we did not detect JC and BK virus DNA sequences
in any of the PCBCL-derived specimens or blood samples
tested. An association of JC and BK virus DNA with lymph-
oma has only been described for HIV-infected non-Hodgkin
lymphoma in children so far (Shiramizu et al, 2000).
In conclusion, polyomavirus DNA (SV40, BKV, JCV) was
not present in detectable amounts in the skin and peripheral
blood mononuclear cells of our patients with PCBCL. To-
gether with the report from Yazdi et al this indicates that in
Germany at least, these viruses are not likely to be asso-
ciated with PCBCL.
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